Mebane, NC, United States of America

Brian Gilmour



 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brian Gilmour: Innovator in Neuropeptide Research

Introduction

Brian Gilmour is a notable inventor based in Mebane, NC (US). He has made significant contributions to the field of neuropeptide research, particularly through his innovative patent related to neuropeptide S receptor antagonists. His work aims to address critical health issues, including substance abuse and relapse.

Latest Patents

Brian Gilmour holds a patent for a "Composition and method for neuropeptide S receptor (NPSR) antagonists." This patent provides neuropeptide S receptor antagonists that effectively bind in functional assays to neuropeptide S receptors. The methods outlined in the patent are intended for the treatment of conditions or disease states that can be improved by blocking the neuropeptide S receptor. These include substance abuse and substance abuse relapse. Additionally, the patent discusses the use of neuropeptide S receptor antagonists in the manufacture of therapeutics and pro-drugs for conditions sensitive to the binding of the neuropeptide S receptor.

Career Highlights

Brian Gilmour is associated with the Research Triangle Institute, where he continues to advance his research and innovation in the field. His work has the potential to lead to significant advancements in therapeutic options for individuals struggling with substance-related issues.

Collaborations

Some of Brian's coworkers include Scott P Runyon and Yanan Zhang, who contribute to the collaborative environment at the Research Triangle Institute.

Conclusion

Brian Gilmour's innovative work in neuropeptide research highlights the importance of scientific advancements in addressing complex health challenges. His contributions through his patent demonstrate a commitment to improving therapeutic options for those affected by substance abuse.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…